GUCY2C (E1Q6S) Rabbit Monoclonal Antibody#29881,Cell Signaling Technology (CST),29881

GUCY2C (E1Q6S) Rabbit Monoclonal Antibody recognizes endogenous levels of total GUCY2C protein.

Host

Rabbit

Reactivity

Human

Application

Western Blotting: 1:1000 Immunoprecipitation: 1:50 Immunofluorescence (Immunocytochemistry): 1:50 - 1:200

Platform ID

BAB229756544

Cell Signaling Technology (CST)

Headquarters

3 Trask Lane Danvers, MA 01923

Contact

Tel: 877-616-2355,978-867-2388
Fax: 877-616-2355

Product Specifications
Scientific Background
Synonyms

Specifications

NameGUCY2C (E1Q6S) Rabbit Monoclonal Antibody#29881
Cat. No.29881
Accession NumberP25092
Gene ID (Entrez)25092, 2984
HostRabbit
SensitivityEndogenous
ReactivityHuman
ApplicationWestern Blotting: 1:1000 Immunoprecipitation: 1:50 Immunofluorescence (Immunocytochemistry): 1:50 - 1:200
Molecular Weight145, 130
ImmunogenIgG
FormulationSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C.Do not aliquot the antibody.
StorageSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C.Do not aliquot the antibody.
Regulatory StatusResearch Use Only

Scientific Background

Guanylyl cyclase C (GUCY2C) is a type I transmembrane glycoprotein whose expression in normal tissue is largely restricted to the apical membranes of polarized epithelial cells of the intestine (1,2). The guanylyl cyclase activity within the intracellular domain of GUCY2C is activated by binding exogenous bacterial enterotoxins and the endogenous peptide hormone agonists, guanylin and uroguanylin, which facilitates production of the second messenger cGMP (3-5). GUCY2C signaling plays a critical role in regulating the metabolism, proliferation, and differentiation of intestinal epithelial cells. These processes are critical for epithelial barrier renewal, water, and ion balance (6-8). Research studies have shown that the GUCY2C signaling axis functions to suppress intestinal tumorigenesis, in part, by restraining AKT activity (9,10). Lesions in the GUCY2C signaling axis that frequently contribute to cellular transformation are associated with a loss of expression of its endogenous ligands, which promotes a compensatory increase in GUCY2C expression. Indeed, GUCY2C expression is maintained in a high percentage of primary and metastatic human colorectal tumors, which has raised interest in therapeutically targeting this receptor (11,12).Valentino, M.A. et al. (2011)J Clin Invest121, 3578-88.Kim, G.W. et al. (2013)Trends Endocrinol Metab24, 165-73.Currie, M.G. et al. (1992)Proc Natl Acad Sci U S A89, 947-51.Kita, T. et al. (1994)Am J Physiol266, F342-8.Schulz, S. et al. (1990)Cell63, 941-8.Li, P. et al. (2007)Am J Pathol171, 1847-58.Li, P. et al. (2007)Gastroenterology133, 599-607.Pitari, G.M. et al. (2001)Proc Natl Acad Sci U S A98, 7846-51.Lin, J.E. et al. (2010)Gastroenterology138, 241-54.Gibbons, A.V. et al. (2013)Cancer Res73, 6654-66.Mathur, D. et al. (2020)Clin Cancer Res26, 2188-2202.Magee, M.S. et al. (2018)Cancer Immunol Res6, 509-516.Alternate NamesDIAR6; GC-C; guanylate cyclase 2C; guanylate cyclase 2C (heat stable enterotoxin receptor); Guanylyl cyclase C; GUC2C; GUCY2C; Heat-stable enterotoxin receptor; hSTAR; Intestinal guanylate cyclase; MECIL; MUCIL; STA receptor; STAR

Synonyms

DIAR6; GC-C; guanylate cyclase 2C; guanylate cyclase 2C (heat stable enterotoxin receptor); Guanylyl cyclase C; GUC2C; GUCY2C; Heat-stable enterotoxin receptor; hSTAR; Intestinal guanylate cyclase; MECIL; MUCIL; STA receptor; STAR

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.